CODX
Income statement / Annual
Last year (2023), Co-Diagnostics, Inc.'s total revenue was $6.81 M,
a decrease of 80.09% from the previous year.
In 2023, Co-Diagnostics, Inc.'s net income was -$35.33 M.
See Co-Diagnostics, Inc.,s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2023
|
FY-2022
|
FY-2021
|
FY-2020
|
FY-2019
|
FY-2018
|
FY-2017
|
FY-2016
|
FY-2015
|
FY-2014
|
| Period Ended |
12/31/2023 |
12/31/2022 |
12/31/2021 |
12/31/2020 |
12/31/2019 |
12/31/2018 |
12/31/2017 |
12/31/2016 |
12/31/2015 |
12/31/2014 |
| Operating Revenue |
$6.81 M
|
$34.22 M
|
$97.89 M
|
$74.55 M
|
$214,974.00
|
$39,911.00
|
$7,662.00
|
$0.00
|
$10,000.00
|
$0.00
|
| Cost of Revenue |
$4.18 M |
$5.48 M |
$11.57 M |
$16.59 M |
$112,431.00 |
$9,391.00 |
$302.00 |
$37,491.00 |
$43,140.00 |
$0.00 |
| Gross Profit |
$2.63 M |
$28.74 M |
$86.31 M |
$57.96 M |
$102,543.00 |
$30,520.00 |
$7,360.00 |
-$37,491.00 |
-$33,140.00 |
$0.00 |
| Gross Profit Ratio |
0.39 |
0.84 |
0.88 |
0.78 |
0.48 |
0.76 |
0.96 |
0 |
-3.31 |
0 |
| Research and Development
Expenses |
$22.96 M
|
$17.44 M
|
$14.96 M
|
$3.19 M
|
$1.37 M
|
$1.36 M
|
$1.00 M
|
$731,474.00
|
$806,913.00
|
$311,476.00
|
| General & Administrative
Expenses |
$14.28 M
|
$14.26 M
|
$11.55 M
|
$8.28 M
|
$3.50 M
|
$3.57 M
|
$3.10 M
|
$796,896.00
|
$846,825.00
|
$482,649.00
|
| Selling & Marketing
Expenses |
$6.86 M
|
$7.34 M
|
$13.40 M
|
$4.67 M
|
$1.06 M
|
$1.17 M
|
$426,711.00
|
$122,105.00
|
$281,101.00
|
$226,652.00
|
| Selling, General &
Administrative Expenses |
$21.14 M
|
$21.61 M
|
$24.95 M
|
$12.94 M
|
$4.56 M
|
$4.74 M
|
$3.52 M
|
$919,001.00
|
$1.13 M
|
$709,301.00
|
| Other Expenses |
$1.23 M |
$1.28 M |
$335,363.00 |
$138,635.00 |
$65,902.00 |
$50,765.00 |
$45,758.00 |
$0.00 |
$43,140.00 |
$0.00 |
| Operating Expenses |
$45.33 M |
$40.33 M |
$40.25 M |
$16.27 M |
$6.00 M |
$6.15 M |
$4.57 M |
$1.69 M |
$1.98 M |
$1.03 M |
| Cost And Expenses |
$49.52 M |
$45.81 M |
$51.82 M |
$32.86 M |
$6.11 M |
$6.16 M |
$4.57 M |
$1.69 M |
$1.98 M |
$1.03 M |
| Interest Income |
$1.16 M |
$704,044.00 |
$45,631.00 |
$97,215.00 |
$36,652.00 |
$19,804.00 |
$3,829.00 |
$0.00 |
$0.00 |
$13,750.00 |
| Interest Expense |
$0.00 |
$14.88 M |
$0.00 |
$0.00 |
$106,437.00 |
$134,947.00 |
$310,233.00 |
$240,720.00 |
$75,189.00 |
$0.00 |
| Depreciation &
Amortization |
$1.23 M
|
$1.31 M
|
$335,363.00
|
$138,635.00
|
$65,902.00
|
$50,765.00
|
$46,060.00
|
$37,491.00
|
$43,140.00
|
$13,596.00
|
| EBITDA |
-$41.48 M
|
-$10.31 M
|
$46.40 M
|
$41.83 M
|
-$6.02 M
|
-$6.09 M
|
-$6.60 M
|
-$1.65 M
|
-$1.92 M
|
-$1.02 M
|
| EBITDA Ratio |
-6.09 |
-0.08 |
0.47 |
0.57 |
-28.02 |
-152.49 |
-591.34 |
0 |
-192.48 |
0 |
| Operating Income Ratio
|
-6.27
|
-0.34
|
0.47
|
0.56
|
-27.42
|
-153.29
|
-595.68
|
0
|
-196.8
|
0
|
| Total Other
Income/Expenses Net |
$4.60 M
|
$8.13 M
|
-$429,157.00
|
$875,425.00
|
-$301,816.00
|
-$153,907.00
|
-$2.40 M
|
-$240,720.00
|
-$75,189.00
|
-$13,751.00
|
| Income Before Tax |
-$38.11 M |
-$18.85 M |
$45.64 M |
$42.57 M |
-$6.20 M |
-$6.27 M |
-$6.96 M |
-$1.93 M |
-$2.04 M |
-$1.05 M |
| Income Before Tax Ratio
|
-5.59
|
-0.55
|
0.47
|
0.57
|
-28.82
|
-157.14
|
-908.28
|
0
|
-204.32
|
0
|
| Income Tax Expense |
-$2.78 M |
-$4.61 M |
$8.98 M |
$90,536.00 |
-$126,444.00 |
-$18,960.00 |
$293,837.00 |
$0.00 |
$0.00 |
$0.00 |
| Net Income |
-$35.33 M |
-$14.24 M |
$36.66 M |
$42.48 M |
-$6.07 M |
-$6.27 M |
-$6.96 M |
-$1.93 M |
-$2.04 M |
-$1.05 M |
| Net Income Ratio |
-5.19 |
-0.42 |
0.37 |
0.57 |
-28.23 |
-157.14 |
-908.28 |
0 |
-204.32 |
0 |
| EPS |
-1.2 |
-0.45 |
1.27 |
1.59 |
-0.36 |
-0.5 |
-0.63 |
-0.17 |
-0.18 |
-0.13 |
| EPS Diluted |
-1.2 |
-0.45 |
1.23 |
1.52 |
-0.36 |
-0.5 |
-0.63 |
-0.17 |
-0.18 |
-0.13 |
| Weighted Average Shares
Out |
$29.35 M
|
$31.48 M
|
$28.87 M
|
$26.72 M
|
$16.76 M
|
$12.48 M
|
$10.96 M
|
$11.06 M
|
$11.06 M
|
$7.86 M
|
| Weighted Average Shares
Out Diluted |
$29.35 M
|
$31.48 M
|
$29.90 M
|
$28.00 M
|
$16.76 M
|
$12.48 M
|
$10.96 M
|
$11.18 M
|
$11.18 M
|
$7.86 M
|
| Link |
|
|
|
|
|
|
|
|
|
|
